| tip : |
ziar |
| Internet legătură într- : |
https://doi.org/10.1177/1078155220914349 |
|
| Echipe de cercetare : |
Toronto - Sunnybrook Health Sciences Center |
| Autor : |
Lingertat-Walsh K, Weilnau J, Cober M P, Ostrenga A, Poon B, Pacita S, Law S, Dupuis LL, Walker SE. |
| titlu : |
Stability of extemporaneously compounded temozolomide 10 mg/mL suspensions in Oral Mix SF in glass and plastic syringes. |
| Référence : |
J Oncol Pharm Practice ;27,1:78–87 2021 |
|
| Nivelul dovezii : |
|
| stabilitatea fizică : |
|
| Stabilitate chimică : |
|
| alte metode : |
|
| Comentarii : |
|
Listele
 Temozolomide
|
 |
 |
 |
 |
150 mg
Temodal® |
|
2-8°C |
 |
| 56 |
 |
|
|
|
 |
|
150 mg
Temodal® |
|
2-8°C |
|
| 56 |
|
|
|
|
 |
|
10 mg
Temodal® |
|
2-8°C |
|
| 56 |
|
|
|
|
|
